Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Freerksen

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Arzneimittel-Forschung|August 1, 1972
A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosyE Freerksen, M Rosenfeld
Arzneimittel-Forschung|October 1, 1992
Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimineE Freerksen, J K Seydel
Chemotherapy|January 1, 1989
Integrated complex combinations for the treatment of opportunistic infections in AIDSE Freerksen, M Rosenfeld, G Spannuth
The Japanese Journal of Tuberculosis and Chest Diseases|July 1, 1970
[Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice]T Matsumiya, E Freerksen, M Rosenfeld
The Japanese Journal of Tuberculosis and Chest Diseases|July 1, 1970
[Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice]T Matsumiya, E Freerksen, M Rosenfeld
Chemotherapy|January 1, 1989
New forms of multidrug therapy for the treatment of leprosy. First report for the practice on rifampicin + sulfamethoxazole-trimethoprim + protionamide and rifampicin + sulfamethoxazole-trimethoprim + isoniazidE Freerksen, M Rosenfeld, G Spannuth
The Japanese Journal of Tuberculosis and Chest Diseases|July 1, 1971
Systemic chemotherapy in mice experimentally infected with Mycobacterium marinumS Hokama, M Rosenfeld, E Freerksen
Chemotherapy|September 1, 1995
Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprimE Freerksen, E W Kanthumkumwa, A R Kholowa
Das Offentliche Gesundheitswesen|September 1, 1984
[Therapy of salmonella carriers]E Freerksen, M Rosenfeld, J Napp, et al.
Chemotherapy|November 1, 1996
Cotrifazid--an agent against malariaE Freerksen, E W Kanthunkumva, A R Kholowa
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Arzneimittel-Forschung|August 1, 1972
A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosyE Freerksen, M Rosenfeld
Arzneimittel-Forschung|October 1, 1992
Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimineE Freerksen, J K Seydel
Chemotherapy|January 1, 1989
Integrated complex combinations for the treatment of opportunistic infections in AIDSE Freerksen, M Rosenfeld, G Spannuth
The Japanese Journal of Tuberculosis and Chest Diseases|July 1, 1970
[Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice]T Matsumiya, E Freerksen, M Rosenfeld
The Japanese Journal of Tuberculosis and Chest Diseases|July 1, 1970
[Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice]T Matsumiya, E Freerksen, M Rosenfeld
Chemotherapy|January 1, 1989
New forms of multidrug therapy for the treatment of leprosy. First report for the practice on rifampicin + sulfamethoxazole-trimethoprim + protionamide and rifampicin + sulfamethoxazole-trimethoprim + isoniazidE Freerksen, M Rosenfeld, G Spannuth
The Japanese Journal of Tuberculosis and Chest Diseases|July 1, 1971
Systemic chemotherapy in mice experimentally infected with Mycobacterium marinumS Hokama, M Rosenfeld, E Freerksen
Chemotherapy|September 1, 1995
Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprimE Freerksen, E W Kanthumkumwa, A R Kholowa
Das Offentliche Gesundheitswesen|September 1, 1984
[Therapy of salmonella carriers]E Freerksen, M Rosenfeld, J Napp, et al.
Chemotherapy|November 1, 1996
Cotrifazid--an agent against malariaE Freerksen, E W Kanthunkumva, A R Kholowa
Pageof 5